Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T12:50:21.014Z.
Calculation as of: 2026-10-06T12:50:21.014Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$2.02B
EBITDA Yield
9.52%
TTM Avg
9.88%
3Y Avg
9.54%
5Y Avg
9.46%
Market Cap
$2.03B
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.03B
EBITDA Yield
4.52%
TTM Avg
5.94%
3Y Avg
10.37%
5Y Avg
12.24%
Market Cap
$1.86B
EBITDA Yield
8.11%
TTM Avg
7.29%
3Y Avg
6.38%
5Y Avg
5.71%
Market Cap
$2.05B
EBITDA Yield
10.81%
TTM Avg
12.30%
3Y Avg
13.98%
5Y Avg
15.61%
Market Cap
$2.10B
EBITDA Yield
8.58%
TTM Avg
8.40%
3Y Avg
9.03%
5Y Avg
8.33%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADARx Pharmaceuticals, Inc. (ADRX) | $1.95B | N/A | N/A | N/A | N/A |
| Allient Inc. (ALNT)vs › | $2.02B | 3.45% | 5.16% | 7.84% | 7.58% |
| Allegiant Travel Company (ALGT)vs › | $2.02B | 9.52% | 9.88% | 9.54% | 9.46% |
| Arxis, Inc. Class A Common Stock (ARXS)vs › | $2.03B | N/A | N/A | N/A | N/A |
| Preformed Line Products Company (PLPC)vs › | $2.03B | 4.52% | 5.94% | 10.37% | 12.24% |
| Enerpac Tool Group Corp. (EPAC)vs › | $1.86B | 8.11% | 7.29% | 6.38% | 5.71% |
| Cimpress plc (CMPR)vs › | $1.85B | 12.25% | 11.09% | 10.95% | 9.52% |
| Werner Enterprises, Inc. (WERN)vs › | $2.05B | 10.81% | 12.30% | 13.98% | 15.61% |
| Trinity Industries, Inc. (TRN)vs › | $2.10B | 8.58% | 8.40% | 9.03% | 8.33% |
| Hub Group, Inc. (HUBG)vs › | $1.74B | 14.89% | 11.30% | 12.56% | 14.65% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
